Stroke avoidance is sometimes all about removal of clots that are threatening to restrict blood flow to crucial neurovascular structures. Clot removal can be facilitated using a metallic, expanding basket type device. One of the main players, Stryker is now trumpeting the global launch of its new Trevo® XP ProVue Retriever, expanding its line of stent-based clot retrieval devices with additional shapes and sizes.
The Trevo ProVue Retrievers are the world’s first stent retrievers with full-length visibility and are built on Stryker’s so-called Trevo technology which has delivered strong clinical results and positive patient outcomes for acute ischemic stroke patients.
Clinical trial results from Stryker’s TREVO and TREVO2 studies have yielded robust clinical evidence, demonstrating high revascularization and a high rate of good clinical outcomes compared to the earlier generation Merci Retriever®.
Physicians participating in the Trevo® Retriever Registry, a multi-center, international data collection study, will now be collecting real world data on the Trevo XP ProVue Retriever following its 510(k) market clearance by the U.S. FDA and clearance in other markets.
“The Trevo XP ProVue Retriever provides some of the best performance of the devices I’ve used over the years to treat acute ischemic stroke. The unique full-length visibility provides key information that we can use to successfully remove clots more efficiently. When combined with the Merci® Balloon Guide Catheter, I feel I have a system that is easy to use and provides the potential for consistently good results,” said Ronald Budzik, M.D., Interventional Neuroradiology/Neurointerventional Surgery; Chair, Neuroscience Clinical Operations Council; Co-Director, Riverside Comprehensive Stroke Center, OhioHealth, Riverside Methodist Hospital, Columbus, Ohio.
Joey D. English, M.D., Ph.D., Director of Neurointerventional Services, California Pacific Medical Center, San Francisco, California added, “The new Trevo XP ProVue Retriever is smooth and easy to use. It has excellent deliverability and the visibility it provides allows me to confidently deploy the device in the best position to capture and remove the clot. I can visualize the clot and strut interaction during the case and this provides valuable feedback for clot removal.”
“The Trevo XP ProVue Retriever is an example of the passion the Stryker Neurovascular team has towards innovating technology that assists physicians in treating their patients who are suffering from Acute Ischemic Stroke,” said Mark Paul, President of Stryker’s Neurovascular division. “We set a new standard in stent retriever technology with the launch of the first Trevo ProVue Retriever. This second generation device expands the ProVue line and demonstrates our ongoing dedication to providing physicians with the most advanced tools available.”
Source: Stryker Corporation, PR Newswire